FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Avkare Lamotrigine Tablets Recall

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle

AVKARE Inc. · Pulaski, TN

Risk level
Class III
Reported by FDA
Jun 10, 2020
Recall ID
D-1289-2020
Check your lot numberHow we source this data

Summary

Avkare recalled Lamotrigine Tablets starting May 28, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1289-2020 on Jun 10, 2020. Reason: Presence of Foreign Substance consistent with granules from desiccant packs used during storage. Status: Terminated.

Why it was recalled

Presence of Foreign Substance consistent with granules from desiccant packs used during storage

Product description

Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.

Lot numbers, UPCs & expiration codes

Lot #: a) 25634, b) 25633; Exp. 09/30/2021

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1289-2020
Classification
Class III
Status
Terminated
Recall initiated
May 28, 2020
FDA report date
Jun 10, 2020
Quantity
4124 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AVKARE Inc.

Original FDA data

Every field from FDA enforcement report D-1289-2020, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Terminated
Country
United States
Event ID
85783
Address
615 N 1st St
Code information
Lot #: a) 25634, b) 25633; Exp. 09/30/2021
Postal code
38478-2403
Report date
Jun 10, 2020
Product type
Drugs
Recall number
D-1289-2020
Classification
Class III
Recalling firm
AVKARE Inc.
Product quantity
4124 bottles
Termination date
Oct 22, 2021
Reason for recall
Presence of Foreign Substance consistent with granules from desiccant packs used during storage
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
May 28, 2020
Initial firm notification
Letter
Center classification date
Jun 4, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1289-2020, published Jun 10, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls